CDE Releases Technical Guidelines for Pilot Registration and Phased Manufacturing of ADCs
The Center for Drug Evaluation (CDE) has issued the “Technical Requirements for Pilot Registration and...
Fineline Cube
Shanghai Pharmaceuticals’ MediTrust Health Partners with Eisai for Comprehensive Patient Services
Shanghai Pharmaceuticals Holding Co., Ltd’s (HKG: 2607, SHA: 601607) subsidiary, MediTrust Health, which specializes in...
Boehringer Ingelheim Partners with Wuhan Union Hospital to Enhance Clinical Research and Development
Boehringer Ingelheim, a leading German pharmaceutical company, has entered into a strategic partnership with Wuhan...
NHSA and MCA Boost Medical Assistance with Enhanced Information Sharing Measures
The National Healthcare Security Administration (NHSA) and the Ministry of Civil Affairs (MCA) have jointly...
Hainan Haiyao Enters JV with Haikou and Xenios AG to Advance ECMO Technology
Hainan Haiyao Co., Ltd (SHE: 000566), a prominent Chinese company, has announced the signing of...
Belief BioMed’s BBM-D101 Receives FDA Orphan Drug and Pediatric Rare Disease Designations for DMD
Belief BioMed has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
Nanjing Leads Biolabs and Aditum Bio Launch Oblenio Bio with Focus on CD19 Tri-Specific Antibody
China-based Nanjing Leads Biolabs Co., Ltd and venture capital firm Aditum Bio have announced the...
Sanofi and Cathay Capital Forge Partnership to Boost Sino-French Pharmaceutical Cooperation
French pharmaceutical giant Sanofi (NASDAQ: SNY) has signed a partnership deal with Cathay Capital, a...
Eisai and GE Healthcare Sign MoU at CIIE to Collaborate on Alzheimer’s Disease Solutions
At the 7th China International Import Expo (CIIE), Japan-based Eisai Co., Ltd (TYO: 4523) entered...
Lohmann & Rauscher Partners with Allmed Medical Products at CIIE for Medical Dressings
Lohmann & Rauscher, a medical group with headquarters in Germany and Austria, has entered into...
I-Mab Appoints Sean (Xi-Yong) Fu as Permanent CEO, Effective November 1, 2024
US-based biopharmaceutical company I-Mab (NASDAQ: IMAB) has announced the appointment of Sean (Xi-Yong) Fu, PhD,...
Novo Nordisk Reports Q3 2024 Financials with 24% YOY Revenue Growth
Denmark-based pharmaceutical company Novo Nordisk A/S (NYSE: NVO) has released its financial results for the...
Shanghai Pharmaceutical Co., Ltd Secures Multiple Partnerships at CIIE
At the 7th China International Import Expo (CIIE), China-based Shanghai Pharmaceutical Co., Ltd (SPH, SHA:...
Siemens Healthineers AG Reports Fiscal 2024 Results with Targeted Revenue Growth
Germany-based medical device giant Siemens Healthineers AG (ETR: SHL) has released its financial results for...
HutchMed to Present Updated Data from Solvleplenib ESLIM-01 Phase III Trial at ASH and ESMO Congress 2024
China-based HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced plans to present new and...
Bayer HealthCare Partners with China Population Welfare Foundation at CIIE for Public Health Initiatives
German pharmaceutical giant Bayer HealthCare (FRA: BAYN) has entered into a partnership agreement with the...
Medtronic Partners with China Resources Guangdong Pharmaceutical at CIIE for Medical Equipment Development
US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong...
Pfizer’s Talzenna (talazoparib) Approved by China’s NMPA for mCRPC Treatment
The National Medical Products Administration (NMPA) website has indicated that Pfizer’s (NYSE: PFE) marketing filing...
Shouyao Holdings Adjusts Development Strategy for SY-1530, Halts Monotherapy Clinical Trials
Beijing-based Shouyao Holdings (Beijing) Co., Ltd (SHA: 688197) has announced a strategic adjustment regarding its...
Nanjing Leads Biolabs Secures FDA Orphan Drug Designation for LBL-034 in Multiple Myeloma Treatment
Nanjing Leads Biolabs Co., Ltd, a China-based biopharmaceutical company, has announced that it has received...